Latest Insider Transactions at Allakos Inc. (ALLK)
This section provides a real-time view of insider transactions for Allakos Inc. (ALLK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Allakos Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Allakos Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 11
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$1,940,000
$97.79 P/Share
|
|
May 10
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
May 10
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$1,920,000
$96.02 P/Share
|
|
Apr 19
2021
|
Harlan Baird Radford Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,100
+50.0%
|
-
|
|
Apr 14
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
Apr 14
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$2,140,000
$107.77 P/Share
|
|
Apr 13
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
Apr 13
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$2,060,000
$103.08 P/Share
|
|
Apr 12
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
Apr 12
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$2,080,000
$104.4 P/Share
|
|
Apr 06
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.21%
|
$10,000
$1.16 P/Share
|
|
Apr 06
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.94%
|
$1,110,000
$111.68 P/Share
|
|
Apr 05
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.1%
|
$20,000
$1.16 P/Share
|
|
Apr 05
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-16.42%
|
$2,260,000
$113.06 P/Share
|
|
Apr 01
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.1%
|
$20,000
$1.16 P/Share
|
|
Apr 01
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-16.42%
|
$2,280,000
$114.4 P/Share
|
|
Mar 29
2021
|
John P Mckearn Director |
SELL
Bona fide gift
|
Indirect |
1,200
-100.0%
|
-
|
|
Mar 26
2021
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
17,308
-12.19%
|
$1,990,420
$115.55 P/Share
|
|
Mar 26
2021
|
John P Mckearn Director |
SELL
Open market or private sale
|
Indirect |
7,439
-86.11%
|
$855,485
$115.0 P/Share
|
|
Mar 22
2021
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
13,148
-7.85%
|
$1,564,612
$119.84 P/Share
|
|
Mar 17
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+7.01%
|
$0
$0.69 P/Share
|
|
Mar 17
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-7.54%
|
$2,420,000
$121.14 P/Share
|
|
Mar 16
2021
|
Steven P James |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+50.0%
|
$0
$0.52 P/Share
|
|
Mar 16
2021
|
Steven P James |
SELL
Open market or private sale
|
Direct |
3,500
-100.0%
|
$423,500
$121.65 P/Share
|
|
Mar 16
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+7.01%
|
$0
$0.69 P/Share
|
|
Mar 16
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-7.54%
|
$2,420,000
$121.76 P/Share
|
|
Mar 15
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+7.01%
|
$0
$0.69 P/Share
|
|
Mar 15
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-7.54%
|
$2,440,000
$122.78 P/Share
|
|
Mar 15
2021
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
6,708
-7.18%
|
$831,792
$124.56 P/Share
|
|
Mar 12
2021
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
4,071
-4.17%
|
$504,804
$124.18 P/Share
|
|
Mar 11
2021
|
Peter A Hudson |
SELL
Open market or private sale
|
Indirect |
20,247
-32.36%
|
$2,510,628
$124.32 P/Share
|
|
Mar 11
2021
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
6,006
-5.8%
|
$744,744
$124.62 P/Share
|
|
Mar 10
2021
|
Peter A Hudson |
SELL
Open market or private sale
|
Indirect |
2,107
-6.94%
|
$261,268
$124.37 P/Share
|
|
Mar 10
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
Mar 10
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$2,420,000
$121.78 P/Share
|
|
Mar 09
2021
|
Peter A Hudson |
SELL
Open market or private sale
|
Indirect |
2,200
-3.43%
|
$272,800
$124.97 P/Share
|
|
Mar 09
2021
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
100
-0.1%
|
$12,500
$125.0 P/Share
|
|
Mar 09
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
Mar 09
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$2,420,000
$121.78 P/Share
|
|
Mar 08
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.36%
|
$0
$0.69 P/Share
|
|
Mar 08
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.55%
|
$2,440,000
$122.78 P/Share
|
|
Mar 05
2021
|
Robert J More |
SELL
Open market or private sale
|
Direct |
12,676
-46.77%
|
$1,495,768
$118.73 P/Share
|
|
Mar 04
2021
|
Guy P Nohra > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,768
-44.57%
|
$2,860,248
$111.33 P/Share
|
|
Mar 04
2021
|
Robert J More |
SELL
Open market or private sale
|
Direct |
15,000
-11.58%
|
$1,665,000
$111.3 P/Share
|
|
Mar 03
2021
|
Robert J More |
SELL
Open market or private sale
|
Direct |
4,878
-3.16%
|
$546,336
$112.81 P/Share
|
|
Mar 03
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
3,189
-2.04%
|
$360,357
$113.56 P/Share
|
|
Mar 03
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+13.91%
|
$20,000
$1.16 P/Share
|
|
Mar 03
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
21,952
-9.02%
|
$2,458,624
$112.92 P/Share
|
|
Mar 02
2021
|
Mark Asbury CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
733
-1.15%
|
$85,761
$117.82 P/Share
|
|
Mar 02
2021
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,890
-1.56%
|
$455,130
$117.82 P/Share
|